Search For "fixed dose combination"
CDSCO "urgently" orders halt on production of 35 unapproved combination dr
Updated : 5 months, 1 week ago IST
The Central Drugs Standard Control Organisation (CDSCO) has issued an urgent directive to all state and Union Territory drug controllers to stop the manufacturing and marketing of certain unapproved Fixed Dose Combination (FDC) drugs.
Read More
After 156 banned drugs, 34 more multivitamins under reviews: Sources
Updated : 1 year, 6 months ago IST
Following the recent ban on 156 drugs, the Government of India is now considering banning 34 additional multivitamins, according to sources.
Read More
India bans 156 commonly used combination drugs citing possible risks to hu
Updated : 1 year, 6 months ago IST
The government said these combination drugs are likely to involve risk to human beings whereas safer alternatives to the said drug are available.
Read More
'Listen to your patients for early identification of Peripheral Neuropathy
Updated : 2 years, 4 months ago IST
Jakarta [Indonesia], November 6: As part of World Diabetes Day 2023, P&G Health, brought together renowned health experts at the '#KNOWTHESIGNS Scientific Forum'. The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN
Read More
Micro Labs Ltd introduces Trisopt: World's first triple drug fixed-dose co
Updated : 2 years, 6 months ago IST
New Delhi [India], August 16: Micro Labs Ltd, a renowned pharmaceutical company, proudly announced the launch of Trisopt, the world's first fixed-dose combination of Brimonidine, Timolol, and Brinzolamide ophthalmic suspension for glaucoma management. Trisopt is an indigenous development fro
Read More
Glenmark launches injection for prevention of chemotherapy-induced nausea,
Updated : 3 years, 1 month ago IST
It is a fixed-dose combination of fosnetupitant (235 mg) and palonosetron (0.25 mg), and is available as a ready-to-dilute IV injection. It is administered as a single infusion 30 minutes prior to the start of each chemotherapy cycle that helps prevent, both, acute and delayed phases of CINV
Read More
Glenmark launches drug for treating type 2 diabetes
Updated : 3 years, 2 months ago IST
This fixed-dose combination has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg), Pioglitazone (15 mg) and Metformin (500mg/1000mg) in a sustained release (SR) formulation, according to the company's statement. It offers patients with type 2 diabetes the con
Read More
Alkem launches first time in India FDC of Dapagliflozin, Sitagliptin and M
Updated : 3 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 6 (ANI/PRNewswire): Alkem Laboratories Limited, the 5th largest Indian pharmaceutical company, has launched for the first time in India, triple drug fixed dose combination (FDC) of Dapagliflozin, Sitagliptin and Metformin under the brand name of Dapanorm
Read More
Glenmark launches sitagliptin and its fixed-dose combinations, at affordab
Updated : 3 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 8 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched sitagliptin and its Fixed Dose Combinations (FDCs), at affordable prices for adults with Type 2 diabetes in India. The company h
Read More
Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin
Updated : 3 years, 10 months ago IST
Mumbai (Maharashtra) [India], April 25 (ANI/PR Newswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, with
Read More
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], October 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed-dose combination (FDC) of its novel, patent-protected, globally researched Sodium-Glucose Co-Transporter Inhibitor (SGLT2i
Read More
Glenmark receives marketing approval for Ryaltris®, an innovative com
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], September 30 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal spray Ryaltris® in 13 countries across the EU and UK.
Read More